Clinical Chemistry Analyzers Market - Forecast(2022 - 2027)

Report Code: HCR 35877 Report Format: PDF + Excel

Clinical Chemistry Analyzers Market Overview

The Clinical Chemistry Analyzers Market size is forecast to reach $15.4 billion by 2026, growing at a CAGR 4.8 % of during the forecast period 2021-2026. Clinical chemistry analyzers are used to calculate the concentration of certain electrolytes, metabolites, drugs in serum, cerebrospinal fluid, and other body fluids among others. It generates an accurate result within the lease period and is designed for extremely advanced technology. It is used to validate health conditions such as nutritional status, liver functions, and kidney functions among others. Different types of tests such as lipid profile, liver panel, and renal panel including therapeutic drugs are used to enhance the metabolic functions. Increasing demand for clinical tests and increasing prevalence of endocrine diseases is the major factors driving the growth of the market. Increasing awareness regarding point of care testing and increasing demand for laboratory automation is set to further enhance the overall market developments of the Clinical Chemistry Analyzers Market for the period 2021-2026.

Report Coverage

The report: “Clinical Chemistry Analyzers Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Clinical Chemistry Analyzers Market. 

By Product: Analyzers, Reagents and Other

By Test Type: Basic Metabolic Panel, Liver Panel, Renal Panel, Lipid Profile, Thyroid Function Panel, Electrolyte Panel, and Specialty Chemical Tests.

By End-Use: Hospitals & Clinics, Diagnostic Laboratories, Research Lab & Institutes, and Others

By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa)

Key Takeaways

  • North America dominated the Clinical Chemistry Analyzers Market in 2020 owing to the increasing incidence of the diabetes and chronic diseases. The Clinical Chemistry Analyzers Market scope for different regions will be provided in the final report.
  • Increasing awareness for preventative healthcare and increasing reagent rental agreements are likely to aid the market growth of the Clinical Chemistry Analyzers Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be Clinical Chemistry Analyzers Market report.
  • Increasing deaths from diabetes and high capital investments is poised to create the hurdles for the Clinical Chemistry Analyzers Market.

Clinical Chemistry Analyzers Market Revenue Share, By Geography, 2020(%)

Clinical Chemistry Analyzers Market

For more details on this report - Request for Sample

Clinical Chemistry Analyzers Market Analysis – By Product

Reagents held the largest share in the Clinical Chemistry Analyzers Market in 2020 and is estimated to grow at a CAGR 5.6% during the forecast period 2021-2026. This is owing to the high economical ability and minimum deviations in performance. Reagents are highly cost effective, high precision, optimum sensitivity, and it ensures minimized performance variation. Reagents are imperative to provide accurate procedures. These benefits help clinicians to use reagents for accurate diagnosis.  Reagents are estimated to register the higher CAGR over the period 2021-2026.

Clinical Chemistry Analyzers Market Analysis – By Test Type

Basic Metabolic Panels held the largest share in the Clinical Chemistry Analyzers Market in 2020 and is estimated to grow at a CAGR 5.4% during the forecast period 2021-2026. This is owing to the increasing incidences of the induced diseases and increasing awareness regarding the point of care testing. Basic metabolic panel comprises of tests that provide clinical information regarding the problems that are caused by chemical imbalance. It is used in applications such as newborn screening to facilitate the early detection of metabolic disorders.  Basic Metabolic Panels are estimated to register the higher CAGR over the period 2021-2026.

Clinical Chemistry Analyzers Market Analysis – By Geography

North America dominated the Clinical Chemistry Analyzers Market with a major share of 36.2% in 2020. This is attributed to the increasing government initiatives and increasing implementation of the guidelines generated by various healthcare organizations, increasing incidences of the cardiac diseases, and increasing technological advancements. Increasing demand for portable clinical chemistry analyzers is also increasing the growth of the market in this region.

However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the advancements in technology in clinical chemistry and increasing awareness regarding the automation & integration of clinical analyzers.

Clinical Chemistry Analyzers Market Drivers

Increasing Incidences of Chronic Diseases

Increasing incidences of chronic diseases is also increasing the growth of the Clinical Chemistry Analyzers Market. This is owing to the increasing incidences of hypertension, cardiovascular diseases, diabetes, and kidney diseases among others. The diagnosis of these diseases are responsible for increasing the number of tests that are prescribed for it such as lipid profile, renal panel, and basic metabolic panel among others. Increasing demand of tests for prevention, treatment, and diagnosis of such diseases are also increasing the growth of the market. Thus, increasing the growth of the market during the forecast period 2021-2026.

Increasing Healthcare Expenditure

Increasing healthcare expenditure is increasing the growth of the Clinical Chemistry Analyzers Market. This is owing to increasing prevalence’s of diseases such as diabetes and obesity. Factors such as increasing need for laboratory automation, increasing awareness regarding preventive healthcare, and increasing elderly population is also increasing the growth of the market. Thus, increasing the growth of the market during the forecast period 2021-2026.

Clinical Chemistry Analyzers Market Challenges

Increasing deaths from diabetes and high capital investments

Some of the factors that are set to impede the growth of the Clinical Chemistry Analyzers Market are increasing deaths from diabetes and high capital investments. High instrument cost is also set to hinder the growth of the market during the forecast period 2021-2026. 

Clinical Chemistry Analyzers Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Clinical Chemistry Analyzers Market. In 2020, the Clinical Chemistry Analyzers Market share is consolidated by the top ten players present in the market. The Clinical Chemistry Analyzers Market, top 10 companies are Abbott Diagnostics, Thermo Fisher Scientific, Randox Laboratories, Ortho Clinical Diagnostics, Johnson & Johnson, Mindray Medical International Ltd., and Roche Diagnostics among others.

Relevant Titles:

Radioimmunoassay Market - Forecast(2021 - 2026)

Report Code: HCR 0364

Urinalysis Market - Forecast(2021 - 2026)

Report Code: HCR 0704


For more Lifesciences and Healthcare related reports, please click here

1. Clinical Chemistry Analyzers Market- Overview
    1.1 Definitions and Scope
2. Clinical Chemistry Analyzers Market- Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product
    2.3 Key trends by Test Type
    2.4 Key trends by End User
    2.5 Key trends by Geography
3. Clinical Chemistry Analyzers Market– Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Clinical Chemistry Analyzers Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Clinical Chemistry Analyzers Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Clinical Chemistry Analyzers Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Clinical Chemistry Analyzers Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Clinical Chemistry Analyzers Market – By Product(Market Size –$Million/$Billion)
    8.1 Reagents
    8.2 Analyzers
    8.3 Others
9. Clinical Chemistry Analyzers Market – By Test Type(Market Size –$Million/$Billion)
    9.1 Basic Metabolic Panels
    9.2 Liver Panels
    9.3 Renal Panels
    9.4 Lipid Profile
    9.5 Thyroid Function Panels
    9.6 Electrolyte Panels
    9.7 Specialty Chemical Tests
10. Clinical Chemistry Analyzers Market – By End User(Market Size –$Million/$Billion)
    10.1 Hospitals & Clinics
    10.2 Diagnostic Laboratories
    10.3 Research Laboratories & Institutes
    10.4 Others
11. Clinical Chemistry Analyzers Market- By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. Clinical Chemistry Analyzers Market- Entropy
13. Clinical Chemistry Analyzers Market– Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Competition Matrix
        13.1.5 Best Practices for Companies
14. Clinical Chemistry Analyzers Market– Key Company List by Country Premium Premium
15. Clinical Chemistry Analyzers Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
 "*Financials for private companies would be provided on a best efforts basis”.